跳至主要内容
临床试验/ACTRN12617001518358
ACTRN12617001518358已完成未知

In young lactose intolerant adults, does the prolonged consumption of A1 beta-casein free milk products improve lactose absorption and tolerance by reduced gastrointestinal inflammation compared to conventional A1 and A2 beta-casein containing milk products

niversity of Auckland0 个研究点目标入组 40 人开始时间: 2017年10月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
20 Years 至 40 Years(—)
性别
All

入选标准

  • 20-40 years
  • BMI 18-28 kg/m2
  • Self-described lactose intolerant
  • Lactose intolerant (confirmed by lactose tolerance test: breath hydrogen and symptoms)
  • No history of gastrointestinal disease or metabolic disease.

排除标准

  • Are not lactose intolerant.
  • Have an allergy to milk.
  • Are diagnosed with gastrointestinal disease (i.e. celiac, Crohn’s, colitis, etc.) or pre-existing metabolic disease.
  • Are currently taking medications expected to interfere with normal digestive or metabolic processes including proton pump inhibitors, laxatives, antibiotics etc.
  • Have a medical history precluding a healthy state: history of myocardial infarction, angina, stroke, cancer or pre-existing diabetes, self-reported alcohol intake exceeding a moderate intake (>28 units per week).

研究者

发起方
niversity of Auckland

相似试验